In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Agena Bioscience

www.agenabioscience.com

Latest From Agena Bioscience

Agena Bioscience Eyes New Year Target For Mass Spec Liquid Biopsy Launch

Agena Bioscience will launch two diagnostic panels for targeted testing of lung and colon cancer in Europe in January. The liquid biopsy technology is based on its benchtop mass spectrometer, the MassArray Dx Analyzer 4.

Cancer In Vitro Diagnostics

Mass Spectrometry Makes Inroads Into The Clinical Lab

The use of mass spectrometry in IVD applications looks to be gaining momentum. In this article, Alina Kim, Sunayana Karra and Akash Kundu of Boston Biomedical Consultants report on new developments and innovations showcased at the American Association for Clinical Chemistry Annual (AACC) & Clinical Lab Expo (CLE) annual meeting that took place this summer. Players at the convention exhibited a range of Class I medical devices, research use only liquid chromatography tandem mass spectrometry (LC-MS/MS), matrix-assisted laser desorption/ionization (MALDI-TOF), inductively coupled plasma mass spectrometry (ICP-MS), sample preparation automation platforms, and software solutions.

In Vitro Diagnostics Cancer

Execs On The Move, August 2016

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

BioPharmaceutical Medical Device

Asia On The Move: Former Pfizer Exec To Head BeiGene’s Manufacturing Ops

The coming of autumn has brought a flurry of personnel changes in Asia, with China oncology startup BeiGene continuing its expansion by hiring more executives, while two genome testing firms have set up R&D subsidiaries in China, further heating up the competition in a red hot area. Change has also taken place at the top of the US industry association PhRMA.

BioPharmaceutical China
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
    • Pharmacogenetics-Pharmacogenomics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Research, Analytical Equipment & Supplies
    • PCR & Amplification Tools
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Agena Bioscience
  • Senior Management
  • Peter Dansky, CEO
  • Contact Info
  • Agena Bioscience
    Phone: (858) 202-9000
    3565 General Atomics Court
    San Diego, CA 92121
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register